Targeted inhibition of HK1 or HK2 can inhibit the aerobic glycolysis of tumor cells, promote mitochondrial oxidative phosphorylation, and inhibit the proliferation and growth of tumor cells, which is a new strategy for tumor treatment (62–64). This evidence concerns the gene HK2 and neoplasm.